Genotyping of the N-acetyltransferase2 Polymorphism in the Prediction of Adverse Drug Reactions to Isoniazid in Japanese Patients

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 4, 2002, Pages 357-362

  Hiratsuka, Masahiro ^a   Takekuma, Yoh ^a   Matsuura, Masaki ^a   Narahara, Kaori ^a   Inoue, Tomoko ^a   Ismail, Samar Hamdy ^b   Endo, Naomi ^b  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

adverse drug reaction; genetic polymorphism; isoniazid; NAT2; pharmacogenetics

Indexed keywords

EID: 18244393817     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.357     Document Type: Article

References (19)

1. Sunahara, S., Urano, M. and Ogawa, M.: Genetical and geographic studies on isoniazid inactivation. Science, 134: 1530-1531 (1961).
2. Agundez, J. A. G., Martinez, C, Olivera, M., Ledesma, M. C., Ladero, J. M. and Bentez, J.: Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population. Clin. Pharmacol. Ther., 56: 202-209 (1994).
3. Cascorbi, I., Drakoulis, N., Brockmoller, J, Maurer, A., Sperling, K. and Roots, I.: Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet., 57: 581-592 (1995).
4. Deguchi, T., Mashimo, M. and Suzuki T.: Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem., 265: 12757-12760 (1990).
5. Ohsako, S. and Deguchi, T.: Cloning and expression of Cdnas for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem., 265: 4630-4634 (1990).
6. Blum, M., Grant, D. M., McBride W., Heim, M. and Meyer, U. A.: Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol., 9: 193-203 (1990).
7. Vatsis, K. P., Weber, W.W., Bell, D.A., Dupret, J.M., Evans, D.A.P., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T. and Yamazoe, Y.: Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17 (1995).
8. Mashimo M., Suzuki, T., Abe, M. and Duguchi, T.: Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum. Genet., 90: 139-143 (1992).
9. Enans, D. A. P.: N-Acetyltransferase. Pharmacol. Ther., 42: 157-234 (1989).
10. Dasta, J. F., Prior, J. A. and Kurzrok, S.: Isoniazidinduced fever. Chest, 75: 196-197 (1979).
11. Henderson, R. P., Davis, H. L. and Self, T. H.: Spiking fever induced by isoniazid. Drug Intell. Clin. Pharm., 17: 741-742 (1983).
12. Gabrail, N. Y.: Severe febrile reaction to isoniazid. Chest, 91: 620-621 (1987).
13. Lee, C. H., Hsiue, T. R., Chen, C. W., Chang, H. Y. and Chen, C. R.: Isoniazid-induced fever. J. Formos Med. Assoc., 95: 632-634 (1996).
14. Eichelbaum, M., Kroemer, H. K. and Mikus, G.: Genetically determined diŝerences in drug metabolism as a risk factor in drug toxicity. Toxicol. Lett., 64-65: 115-122 (1992).
15. Ohno, M., Yamaguchi, I., Yamamoto, I., Fukuda, T., Yokota, S., Maekura, R., Ito, M., Yamamoto, Y., Ogura, T., Maeda, K., Komuta, K., Igarashi, T. and Azuma, J.: Slow N-acetyltransferase 2 genotype aŝects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Int. J. Tuberc. Lung Dis., 4: 256-261 (2000).
16. Yale, H. L., Losee, K., Martins, J., Holsing, M., Perry, F. M. and Bernstein, J.: Chemotherapy of experimental tuberculosis. J. Am. Chem. Soc., 75: 1933-1942 (1953).
17. Hiratsuka, M., Agatsuma, Y., Omori, F., Narahara, K., Inoue, T., Kishikawa, Y. and Mizugaki M.: High throughput detection of drug-metabolizing enzyme polymorphisms by fluorogenic 5? nuclease chain reaction assay. Biol. Phram. Bull., 23: 1131-1135 (2000)
18. Seifart, H. I., Gent, W. L., Parkin, D. P., van Jaarsveld, P. P. and Donald, P. R.: High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids. J. Chromatogr. B., 674: 269-275 (1995).
19. Seifart, H. I., Parkin, D. P., Botha, F. J. H., Donald, P. R. and Van Der Walt, B. J.: Population screening for isoniazid acetylator phenotype. Pharmacoepidemiol. Drug Safety, 10: 127-134 (2001).